Flora Doffe
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
High throughput assessment of viability in 2D and 3D cell culture.
Journal: Methods in cell biology
Published: July 13, 2026
Trial watch: antibody-drug conjugates in cancer therapy.
Journal: Oncoimmunology
Published: May 03, 2026
Assessing cancer cell heterogeneity in patient-derived tumoroids.
Journal: Methods in cell biology
Published: March 30, 2026
Assessing spheroid viability in high throughput.
Journal: Methods in cell biology
Published: March 30, 2026
Trial Watch - bispecific T cell engagers and higher-order multispecific immunotherapeutics.
Journal: Oncoimmunology
Published: February 17, 2026
Patritumab deruxtecan induces immunogenic cell death.
Journal: Oncoimmunology
Published: June 03, 2025
Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation.
Journal: Cell reports. Medicine
Published: March 21, 2025
Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening.
Journal: Exploration of targeted anti-tumor therapy
Published: August 08, 2022
TP53_PROF: a machine learning model to predict impact of missense mutations in TP53.
Journal: Briefings in bioinformatics
Published: September 06, 2021
Jejunum-derived NF-κB reporter organoids as 3D models for the study of TNF-alpha-induced inflammation.
Journal: Scientific reports
Published: August 23, 2021
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.
Journal: Cell death and differentiation
Published: March 24, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026